Unknown

Dataset Information

0

Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers.


ABSTRACT: BACKGROUNDA patient-derived organoid (PDO) platform may serve as a promising tool for translational cancer research. In this study, we evaluated PDO's ability to predict clinical response to gastrointestinal (GI) cancers.METHODSWe generated PDOs from primary and metastatic lesions of patients with GI cancers, including pancreatic ductal adenocarcinoma, colorectal adenocarcinoma, and cholangiocarcinoma. We compared PDO response with the observed clinical response for donor patients to the same treatments.RESULTSWe report an approximately 80% concordance rate between PDO and donor tumor response. Importantly, we found a profound influence of culture media on PDO phenotype, where we showed a significant difference in response to standard-of-care chemotherapies, distinct morphologies, and transcriptomes between media within the same PDO cultures.CONCLUSIONWhile we demonstrate a high concordance rate between donor tumor and PDO, these studies also showed the important role of culture media when using PDOs to inform treatment selection and predict response across a spectrum of GI cancers.TRIAL REGISTRATIONNot applicable.FUNDINGThe Joan F. & Richard A. Abdoo Family Fund in Colorectal Cancer Research, GI Cancer program of the Mayo Clinic Cancer Center, Mayo Clinic SPORE in Pancreatic Cancer, Center of Individualized Medicine (Mayo Clinic), Department of Laboratory Medicine and Pathology (Mayo Clinic), Incyte Pharmaceuticals and Mayo Clinic Hepatobiliary SPORE, University of Minnesota-Mayo Clinic Partnership, and the Early Therapeutic program (Department of Oncology, Mayo Clinic).

SUBMITTER: Hogenson TL 

PROVIDER: S-EPMC9746806 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers.

Hogenson Tara L TL   Xie Hao H   Phillips William J WJ   Toruner Merih D MD   Li Jenny J JJ   Horn Isaac P IP   Kennedy Devin J DJ   Almada Luciana L LL   Marks David L DL   Carr Ryan M RM   Toruner Murat M   Sigafoos Ashley N AN   Koenig-Kappes Amanda N AN   Olson Rachel Lo RL   Tolosa Ezequiel J EJ   Zhang Cheng C   Li Hu H   Doles Jason D JD   Bleeker Jonathan J   Barrett Michael T MT   Boyum James H JH   Kipp Benjamin R BR   Mahipal Amit A   Hubbard Joleen M JM   Scheffler Hanson Temperance J TJ   Petersen Gloria M GM   Dasari Surendra S   Oberg Ann L AL   Truty Mark J MJ   Graham Rondell P RP   Levy Michael J MJ   Zhu Mojun M   Billadeau Daniel D DD   Adjei Alex A AA   Dusetti Nelson N   Iovanna Juan L JL   Bekaii-Saab Tanios S TS   Ma Wen Wee WW   Fernandez-Zapico Martin E ME  

JCI insight 20221122 22


BACKGROUNDA patient-derived organoid (PDO) platform may serve as a promising tool for translational cancer research. In this study, we evaluated PDO's ability to predict clinical response to gastrointestinal (GI) cancers.METHODSWe generated PDOs from primary and metastatic lesions of patients with GI cancers, including pancreatic ductal adenocarcinoma, colorectal adenocarcinoma, and cholangiocarcinoma. We compared PDO response with the observed clinical response for donor patients to the same tr  ...[more]

Similar Datasets

2022-10-12 | GSE212014 | GEO
| PRJNA873279 | ENA
| S-EPMC3264936 | biostudies-other
| S-EPMC4087144 | biostudies-literature
| S-EPMC6470207 | biostudies-literature
| S-EPMC9312735 | biostudies-literature
| S-EPMC11680479 | biostudies-literature
| S-EPMC3177868 | biostudies-literature
| S-EPMC10587945 | biostudies-literature
| S-EPMC3767594 | biostudies-literature